The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

Share Price Information for Phoenix Group Holdings (PHNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 519.50
Bid: 513.00
Ask: 551.00
Change: 0.00 (0.00%)
Spread: 38.00 (7.407%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 519.50
PHNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes Announcement

29 Jun 2022 16:00

RNS Number : 6940Q
Phoenix Group Holdings PLC
29 June 2022
 

LEI: 2138001P49OLAEU33T68

 

29 June 2022

 

Phoenix Group Holdings plc - Board Changes

 

The Board of Phoenix Group Holdings plc ("Phoenix Group" or "the Group") is pleased to announce the appointment of Katie Murray as Chair of the Board Audit Committee, with effect from 1 September 2022, subject to regulatory approval.

 

Ms Murray joined the Board as an independent Non-Executive Director on 1 April 2022, bringing strong finance and accounting skills and knowledge to the Group, in addition to a breadth of experience gained from senior executive roles in the banking and insurance sectors.

 

Ms Murray will replace Alastair Barbour as Chair of the Board Audit Committee upon his appointment as interim Chairman from 1 September (as announced in February this year). 

 

Commenting on Ms Murray's additional appointment, Nicholas Lyons, Phoenix Group Chairman, said: "I am very pleased that Katie will be assuming the role of Board Audit Committee Chair in September. As the Group Chief Financial Officer of the NatWest Group, and having held senior executive financial roles, Katie will bring great insight to the work of the committee having operated alongside a number of Audit Chairs during her career. This is a key role within the Group and I have no doubt that Katie will provide great leadership for the committee."

 

In addition, the Group Board is pleased to announce the appointment of Maggie Semple as the Group's Designated Non-Executive Director for Workforce Engagement, with effect from 1 July 2022.

 

Ms Semple joined the Board as an independent Non-Executive Director on 1 June 2022, adding a breadth of knowledge to the Group through experience as a Non-Executive Director in a number of different organisations, such as Her Majesty's Court Service, the Criminal Cases Review Commission, the Ministry of Justice (Chair of Audit, Risk & Compliance) and McDonald's Restaurants. She has a passion for sustainability, ethics and inclusivity.

 

Ms Semple will replace Karen Green as the Group's Designated Non-Executive Director for Workforce Engagement following Ms Green's appointment as the Board Senior Independent Director on 5 May 2022, subject to regulatory approval.

 

Nicholas Lyons, Phoenix Group Chairman, commenting on Ms Semple's appointment said: "The role of the Group's Designated Non-Executive Director for Workforce Engagement provides a critical link between the Board and our Phoenix colleagues, ensuring we stay connected throughout the year. I am pleased that Maggie will be taking on this important position and trust that she will be a beacon of engagement for colleagues. I would like to thank Karen for her service as our Designated Non-Executive Director for Workforce Engagement to date."

 

This announcement is made in accordance with the requirements under Listing Rule 9.6.11R.

 

Enquiries:

Media Douglas Campbell

Teneo

+44 (0)7753 136628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0) 204 559 3031

Investors Claire Hawkins, Corporate Affairs Director, Phoenix Group +44 (0) 204 559 3161

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0) 204 559 3145

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBSGDLUUDDGDC
Date   Source Headline
3rd May 202411:04 amRNSAnnouncement of Early Redemption
1st May 202411:23 amRNSTotal Voting Rights
12th Apr 20244:41 pmRNSSupplemental Circular to the 2024 Notice of AGM
10th Apr 20249:43 amRNSDirector/PDMR Shareholding
9th Apr 20248:33 amRNSDirector/PDMR Shareholding
8th Apr 20242:15 pmRNSNotice of AGM
3rd Apr 20241:02 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:26 pmRNSTotal Voting Rights
2nd Apr 20244:45 pmRNSDirector/PDMR Shareholding
28th Mar 20245:40 pmRNSDirector/PDMR Shareholding
27th Mar 20244:20 pmRNSAnnual Financial Report
27th Mar 20242:45 pmRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNS2023 Annual Financial Report
6th Mar 20242:00 pmRNSDirector/PDMR Shareholding
1st Mar 20249:35 amRNSTotal Voting Rights
6th Feb 20245:17 pmRNSDirector/PDMR Shareholding
2nd Feb 202410:56 amRNSTotal Voting Rights
1st Feb 20247:00 amRNS2023 Trading Statement
8th Jan 20245:09 pmRNSDirector/PDMR Shareholding
2nd Jan 20243:15 pmRNSTotal Voting Rights
11th Dec 20236:13 pmRNSBlock listing Interim Review
6th Dec 20234:28 pmRNSDirector/PDMR Shareholding
5th Dec 202311:42 amRNSFinal Result of Tender Offer
5th Dec 202310:22 amRNSIndicative Result of Tender Offer
5th Dec 20237:10 amRNSPublication of Final Terms
1st Dec 202311:46 amRNSTotal Voting Rights
28th Nov 20235:46 pmRNSIssue of Debt and Tender Maximum Acceptance Amount
27th Nov 20238:20 amRNSTender Offers and New Issue
24th Nov 202311:05 amRNSDirector Declaration
23rd Nov 20232:00 pmRNSPublication of Supplementary Prospectus
23rd Nov 202310:00 amRNSDirectorate Change
13th Nov 20237:00 amRNSUpgrade of near-term cash generation targets
7th Nov 20235:10 pmRNSDirector/PDMR Shareholding
1st Nov 20232:07 pmRNSDirector/PDMR Shareholding
31st Oct 20232:30 pmRNSHolding(s) in Company
25th Oct 20231:17 pmRNSDirector/PDMR Shareholding
25th Oct 20231:16 pmRNSDirector/PDMR Shareholding
9th Oct 202312:40 pmRNSDirector/PDMR Shareholding
9th Oct 202311:20 amRNSDirector/PDMR Shareholding
4th Oct 202310:00 amRNSBoard Changes
2nd Oct 20233:00 pmRNSPublication of Supplementary Prospectus
2nd Oct 20231:35 pmRNSTotal Voting Rights
29th Sep 20237:00 amRNSDirector/PDMR Shareholding
28th Sep 20232:46 pmRNSDirector/PDMR Shareholding
28th Sep 202312:49 pmRNSAvailability of Interim Financial Report
28th Sep 20237:00 amRNSInterim Financial Report
18th Sep 20237:00 amRNS2023 Interim Results
14th Sep 202310:00 amRNSHY23 reporting update
8th Sep 20239:33 amRNSDirector/PDMR Shareholding
1st Sep 20231:29 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.